Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imaging sites SEOUL, South Korea, May 19, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider...

Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care

Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care

Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At this year's...

menu
menu